GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 74 filers reported holding GALENA BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $455,000 | -22.4% | 1,301,165 | +3.4% | 0.00% | – |
| Q2 2016 | $586,000 | -64.9% | 1,258,625 | +2.5% | 0.00% | -100.0% |
| Q1 2016 | $1,669,000 | +2.9% | 1,227,715 | +11.2% | 0.00% | 0.0% |
| Q4 2015 | $1,622,000 | -6.2% | 1,103,979 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $1,729,000 | -6.3% | 1,094,592 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $1,846,000 | +57.2% | 1,086,133 | +28.5% | 0.00% | 0.0% |
| Q1 2015 | $1,174,000 | +10.4% | 845,146 | +20.0% | 0.00% | 0.0% |
| Q4 2014 | $1,063,000 | -26.8% | 704,579 | -0.1% | 0.00% | 0.0% |
| Q3 2014 | $1,453,000 | -31.9% | 705,465 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $2,135,000 | +46.7% | 697,955 | +19.9% | 0.00% | 0.0% |
| Q1 2014 | $1,455,000 | -40.0% | 582,268 | +19.0% | 0.00% | -50.0% |
| Q4 2013 | $2,426,000 | +146.3% | 489,295 | +12.8% | 0.00% | +100.0% |
| Q3 2013 | $985,000 | +33.1% | 433,721 | +30.0% | 0.00% | 0.0% |
| Q2 2013 | $740,000 | – | 333,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |